Garadacimab is under clinical development by CSL and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase II drugs for Idiopathic Pulmonary Fibrosis have a 35% phase ...

In the case of fibrotic pulmonary diseases such as idiopathic pulmonary fibrosis (IPF), the bleomycin ... These data were further corroborated with histological tissue staining and fibrosis ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

Forbes (Robertson) Masson (born 17 August 1963 in Falkirk) is a Scottish actor and writer. He is an Associate Artist with the Royal Shakespeare Company. He is best known for his roles in classical ...

It was announced yesterday (December 31) that legendary BBC DJ Johnnie Walker had died at the age of 79. The veteran radio star hosted BBC show Sounds Of The 70s and The Rock Show, but stepped ...

over 26 weeks in patients with idiopathic pulmonary fibrosis (IPF). “The ELEVATE IPF trial broke new ground in Phase 2 trial design in IPF; this was the first time that a new therapy ...

Familial pulmonary fibrosis (FPF) is a devastating interstitial lung disease (ILD) characterized by progressive scarring of lung parenchyma, most commonly manifesting as idiopathic pulmonary fibrosis ...

Trichrome Masson staining, immunohistochemistry for α-smooth muscle actin, fibroblast activation protein, CD34 and erg, in situ hybridization for TGF-β1 and analysis of selected fibrosis-related ...